SCHOOL OF MEDICINE

Department of Medicine

Hematology/Oncology

Drug Development/Delivery/Analysis

Basic Science Research

Faculty:

Asok Antony, M.D.
Sherif Farag, M.D., Ph.D.
Bryan Schneider, M.D.
John Turchi, Ph.D.


Investigators involved in drug development are targeting novel pathways and cellular processes critical for tumor formation and progression.



Active Research Awards:

Principal Investigator Funding Agency Project Title
Robert Hickey U.S. Army Development of a Breast Cancer Selective therapeutic Agent
Kathy Miller The Breast Cancer Research Foundation Genomic and Proteomic Analysis of Docetaxel and Capecitabine as Primary Chemotherapy for Stage II-III Breast Cancer
Kathy Miller Susan G. Komen Breast Cancer Foundation EphA2, a novel target for breast cancer therapy
George Sledge Jr. The Breast Cancer Research Foundation Therapeutic Targeting of Breast Cancer
Attaya Suvannasankha Multiple Myeloma Research Foundation From laboratory to clinic: Dimethylaminoparthenolide (DMAPT) in myeloma
John Turchi Flight Attendant Medical Research Institute Analysis of DNA repair capacity to predict and target chemoresistant small cell lung cancer
John Turchi NIH – National Cancer Institute Recognition and Repair of Cisplatin-DNA Damage